Table 4.
Guide to Malaria Pharmacology Content Breakdown | |
---|---|
Targets | 30 |
Ligands | 72 |
Ligands (approved drugs) | 19 |
Ligands (WHO essential lists) | 17 |
Targets with quantitative ligand interactions | 20 |
Targets with approved drug interactions | 4 |
Ligands with interactions | 67 |
Ligands with interaction to known targets | 38 |
Ligands with interaction to unknown targets | 34 |
Ligands with quantitative interactions (approved drugs) | 65 (18) |
Ligands with clinical use summaries (approved drugs) | 39 (19) |